HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated letters from lawmakers outlining the threats ...
The United States Food and Drug Administration (FDA) recently released a draft guidance, Expedited Program for Serious ...
Adial Pharmaceuticals (ADIL) announced a “positive” response from the U.S. FDA regarding its proposed in vitro bridging strategy for AD04. The ...
The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...
However, the medication's modest effectiveness and lengthy development process underscore ... Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs ...
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
Jeanne Shaheen, D-N.H., the ranking Democrat on the Appropriations Committee’s subcommittee on Agriculture, Rural Development ... They underscore that the FDA’s drug, device and tobacco ...